Fulvestrant EP et USP specificationes habet.
CAS NumberI¼ 129453-61-8
Formulae hypotheticaeï¼C32H47F5O3SSynonyma:(7a,17b)-7-[9-[(4,4,5,5,5-Pentafluorpentyl)sulfinyl]nonyl]estra-1,3,5(10)-triene-3,17-diol.
Fulvestrare adhibetur in cancro pectoris metastatico hormone receptori (HR) metastatico positivo in foeminis postmenopausalibus cum morborum progressu necnon HR-positivo, HER2-negativo provectio carcinomatis pectoris in compositione cum palbociclib in mulieribus cum progressu morborum post therapiam endocrinam. Datur ab clystere in musculos.
Ordinationes
Fulvestrant EP et USP specificationes habet.